United States to India: Syringe Import Trade Route
India has recorded 480 verified shipments of Syringe imported from United States, representing a combined trade value of $6.8M USD. This corridor is served by 104 active United States exporters, with an average shipment value of $14.2K USD. The leading United States supplier is NEW LIFE MEDICALS (USA) INC.,, which accounts for 25% of total import value with 3 shipments worth $1.7M USD. On the buying side, ZYDUS LIFESCIENCES LIMITED is the largest Indian importer with $1.7M USD in purchases. The top 3 suppliers — NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA FINECHEM LLC, FISHER CLINICAL SERVICES — together control 44% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The United States to India Syringe corridor is one of India's established pharmaceutical import routes from United States, with 480 shipments documented worth a combined $6.8M USD. The route is dominated by NEW LIFE MEDICALS (USA) INC.,, which alone accounts for roughly 25% of all import value, reflecting the consolidated nature of United States's syringe export sector.
Across 104 active United States suppliers, the average shipment value stands at $14.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 18.1%, placing it at rank #18 among India's top syringe import origins globally.
On the Indian buyer side, key Indian importers include ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, KERRY INDEV LOGISTICS PRIVATE LIMITED and 55 others. ZYDUS LIFESCIENCES LIMITED is the single largest Indian importer with 4 shipments valued at $1.7M USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top port of entrySAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#18
- Annual growth+18.1%
- Demand growth+15.6%
- Regulatory ease67/100
Top 10 Syringe Exporters from United States to India
Showing top 10 of 104 United States suppliers exporting Syringe to India, ranked by total trade value (USD)
| Rank | Supplier (United States Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NEW LIFE MEDICALS (USA) INC., Avg $561.7K per shipment | 3 | $1.7M | 24.8% |
| 2 | ESPEE BIOPHARMA FINECHEM LLC Avg $30.1K per shipment | 23 | $691.9K | 10.2% |
| 3 | FISHER CLINICAL SERVICES Avg $296.2K per shipment | 2 | $592.4K | 8.7% |
| 4 | ESPEE BIOPHARMA & FINECHEM LLC Avg $15.7K per shipment | 30 | $471.6K | 6.9% |
| 5 | JUPITER CLINICAL SERVICES INC Avg $88.1K per shipment | 5 | $440.6K | 6.5% |
| 6 | CRYOLIFE INC Avg $72.4K per shipment | 6 | $434.2K | 6.4% |
| 7 | ORMCO CORPORATION Avg $2.0K per shipment | 134 | $263.7K | 3.9% |
| 8 | AMSTERDAM PHARMA(APTEKA RX INC.) Avg $225.7K per shipment | 1 | $225.7K | 3.3% |
| 9 | Espee Biopharma & Finechem LLC Avg $23.8K per shipment | 8 | $190.3K | 2.8% |
| 10 | SANOFI-AVENTIS SINGAPORE PTE LTD Avg $165.2K per shipment | 1 | $165.2K | 2.4% |
This table shows the top 10 of 104 United States companies exporting syringe to India, ranked by total trade value. The listed exporters are: NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA FINECHEM LLC, FISHER CLINICAL SERVICES, ESPEE BIOPHARMA & FINECHEM LLC, JUPITER CLINICAL SERVICES INC, CRYOLIFE INC, ORMCO CORPORATION, AMSTERDAM PHARMA(APTEKA RX INC.), Espee Biopharma & Finechem LLC, SANOFI-AVENTIS SINGAPORE PTE LTD. NEW LIFE MEDICALS (USA) INC., is the dominant supplier with 3 shipments worth $1.7M USD, giving it a 25% market share. The top 3 suppliers together account for 44% of the total trade value on this route.
Showing top 10 of 104 total United States exporters on the United States to India Syringe import route.
Top 10 Indian Syringe Importers from United States
Showing top 10 of 58 known Indian buyers receiving Syringe shipments from United States, ranked by import value
On the receiving end of this trade route, the leading Indian importers of United States syringe include ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, KERRY INDEV LOGISTICS PRIVATE LIMITED, B L LIFESCIENCES PRIVATE LIMITED, SANOFI HEALTHCARE INDIA PRIVATE LIMITED, among 58 total buyers. The largest importer is ZYDUS LIFESCIENCES LIMITED, accounting for $1.7M USD across 4 shipments — representing 25% of all syringe imports from United States on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | 4 | $1.7M | 24.9% |
| 2 | DR.REDDY'S LABORATORIES LTD | 13 | $1.3M | 19.3% |
| 3 | KERRY INDEV LOGISTICS PRIVATE LIMITED | 99 | $560.8K | 8.2% |
| 4 | B L LIFESCIENCES PRIVATE LIMITED | 12 | $480.2K | 7.1% |
| 5 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | 3 | $292.2K | 4.3% |
| 6 | CIPLA LIMITED | 7 | $279.5K | 4.1% |
| 7 | NOBEL BIOCARE INDIA PRIVATE LIMITED | 130 | $256.8K | 3.8% |
| 8 | LUPIN LTD | 2 | $192.6K | 2.8% |
| 9 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 8 | $190.3K | 2.8% |
| 10 | ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED | 1 | $155.6K | 2.3% |
Showing top 10 of 58 Indian Syringe importers from United States on this route.
Top 10 Syringe Formulations Imported from United States
Showing top 10 of 262 product formulations shipped on the United States to India Syringe route, ranked by trade value
India imports a wide range of syringe formulations from United States, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML(SINGLE-DOSE PREFILLED SYRINGES))(TL NO:TL/AZ/23/000275) FOR R&D PUSOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML(SINGLE — accounts for $994.4K USD across 1 shipments. There are 262 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML(SINGLE-DOSE PREFILLED SYRINGES))(TL NO:TL/AZ/23/000275) FOR R&D PUSOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML(SINGLE | 1 | $994.4K | 14.6% |
| 2 | SOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML) (SINGLE-DOSE PREFILLED SYRINGES) (TL NO:TL/AZ/23/000275) FOR R&DSOMATULINE? DEPOT (LANREOTIDE) INJECTION (120MG/0.5ML) (SING | 2 | $690.8K | 10.2% |
| 3 | BG3515-5-G BIOGLUE - SURGICAL ADHESIVE WITH SYRINGE DELIVERY SYSTEM 5ML 5 PER PACK | 2 | $338.8K | 5.0% |
| 4 | Orencia (abatacept)injection 50 mg/0.4 ml Labeled carton of4 pre-filled Syringes(With a passive needle Safety guard)MarOrencia (abatacept)injection 50 mg/0.4 ml Labeled carton of | 1 | $311.8K | 4.6% |
| 5 | OrenOrencia (abatacept) Injection 87.5 mg / 0.7 mL Labeled Carton of 4 Pre-filled Syringes (with a passive needle safetyOrenOrencia (abatacept) Injection 87.5 mg / 0.7 mL Labeled C | 1 | $280.6K | 4.1% |
| 6 | SOMATULINE DEPOT (LANREOTIDE ACETATE INJECTION) 60MG/0.2ML |SYRINGE-1X0.2ML| , Pack Size: 1x0.2ML | 1 | $225.7K | 3.3% |
| 7 | Aranesp 200mcg/ml,100mcg PFS NDC #: 55513-0025-04(Pack Size:4 Syringes/ Pack) | 2 | $191.8K | 2.8% |
| 8 | SYNVISC ONE INJECTION 1 X 6 ML (HYLAN POLYMER A&B GF-20 PREFILLED SYRINGE 8MG/ML) (ASS. B/E PROVISIONALY)SYNVISC ONE INJECTION 1 X 6 ML (HYLAN POLYMER A&B GF-20 PREF | 1 | $165.2K | 2.4% |
| 9 | LUCENTIS RANIBIZUMAB INJECTION SOLUTION 0.5MG 0.05 ML OF 10MG/ML 1 IN 1 CARTON 0.05ML IN 1 SYRINGE FOR TESTING | 1 | $164.8K | 2.4% |
| 10 | COPELLOR AUTOINJECTOR (IXEKIZUMAB) 80MG X 1PEND IN (SOL. FORINJ.80MG/ML IN PF.AUTOINJECTOR & PR.SYRINGE)(B.N.D553575AT) | 1 | $155.6K | 2.3% |
Showing top 10 of 262 Syringe formulations imported from United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Indian Ports of Entry
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 132 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's syringe imports from United States are driven primarily by a handful of large-scale United States manufacturers. NEW LIFE MEDICALS (USA) INC., with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 104 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA FINECHEM LLC, FISHER CLINICAL SERVICES — together account for 44% of total trade value on this route. The average shipment value of $14.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as somatuline? depot (lanreotide) injection (120mg/0.5ml) (single-dose prefilled syringes) (tl no:tl/az/23/000275) for r&dsomatuline? depot (lanreotide) injection (120mg/0.5ml) (sing and bg3515-5-g bioglue - surgical adhesive with syringe delivery system 5ml 5 per pack, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States supplier.
On the buying side, ZYDUS LIFESCIENCES LIMITED is the largest importer with 4 shipments worth $1.7M USD — representing 25% of all syringe imports from United States on this route. A total of 58 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.8M
- Avg. Shipment
- $14.2K
- Suppliers
- 104
- Buyers
- 58
- Transit (Sea)
- ~26 days
- Annual Growth
- +18.1%
Reverse Direction
India → United States — Syringe (Export)Unlock the Full United States to India Syringe Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 480 shipments on this route.
Frequently Asked Questions — United States to India Syringe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which United States companies export Syringe to India?
The leading United States exporters of Syringe to India are NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA FINECHEM LLC, FISHER CLINICAL SERVICES. NEW LIFE MEDICALS (USA) INC., holds the largest market share at approximately 25% of total trade value on this route.
Q What is the total value of Syringe imports from United States to India?
India imports Syringe from United States worth approximately $6.8M USD across 480 recorded shipments. The average value per shipment is $14.2K USD.
Q Which Indian ports receive Syringe from United States?
The most active Indian port of entry is SAHAR AIR CARGO ACC (INBOM4) with 132 shipments. United States exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from United States to India for Syringe?
The average transit time for Syringe shipments from United States to India is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the United States to India Syringe import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.1% with demand growth tracking at 15.6%. The route is ranked #18 among India's top Syringe import origins globally.
Q How many United States suppliers are active on this Syringe import route?
There are currently 104 active United States suppliers exporting Syringe to India. The market is moderately concentrated with NEW LIFE MEDICALS (USA) INC., accounting for 25% of total shipment value.
Q Who are the main Indian importers of Syringe from United States?
The leading Indian importers of Syringe from United States include ZYDUS LIFESCIENCES LIMITED, DR.REDDY'S LABORATORIES LTD, KERRY INDEV LOGISTICS PRIVATE LIMITED, B L LIFESCIENCES PRIVATE LIMITED, SANOFI HEALTHCARE INDIA PRIVATE LIMITED. ZYDUS LIFESCIENCES LIMITED is the largest buyer with 4 shipments worth $1.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Syringe.
- 2.Supplier/Buyer Matching: 104 Indian exporters and 58 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 480 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
480 Verified Shipments
104 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists